Assembly Actions - Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 05, 2018 | committed to rules returned to senate repassed assembly |
May 14, 2018 | amended on third reading 5332a |
May 14, 2018 | vote reconsidered - restored to third reading returned to assembly recalled from senate |
Mar 20, 2018 | referred to health delivered to senate passed assembly |
Jan 03, 2018 | ordered to third reading cal.381 returned to assembly died in senate |
Mar 13, 2017 | referred to health delivered to senate passed assembly |
Mar 09, 2017 | advanced to third reading cal.123 |
Mar 07, 2017 | reported |
Mar 01, 2017 | reported referred to codes |
Feb 08, 2017 | referred to health |
Archive: Last Bill Status - Passed Assembly
- Introduced
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
Your Voice
Actions
Bill Amendments
A5332 - Details
A5332 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5332 2017-2018 Regular Sessions I N A S S E M B L Y February 8, 2017 ___________ Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to the use of psycho- tropic medications in nursing homes and adult care facilities THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 280-c to read as follows: § 280-C. USE OF PSYCHOTROPIC MEDICATIONS IN NURSING HOMES AND ADULT CARE FACILITIES. 1. AS USED IN THIS SECTION: (A) "PSYCHOTROPIC MEDICATION" MEANS A DRUG THAT AFFECTS BRAIN ACTIV- ITIES ASSOCIATED WITH MENTAL PROCESSES AND BEHAVIOR, INCLUDING, BUT NOT LIMITED TO, ANTIPSYCHOTICS, ANTIDEPRESSANTS, ANTIANXIETY DRUGS OR ANXIO- LYTICS, AND HYPNOTICS; (B) "LAWFUL REPRESENTATIVE" MEANS, WHERE A PATIENT LACKS CAPACITY TO CONSENT TO HEALTH CARE, A PERSON AUTHORIZED TO CONSENT ON BEHALF OF THE PATIENT, INCLUDING, BUT NOT LIMITED TO, A HEALTH CARE AGENT AUTHORIZED BY A HEALTH CARE PROXY UNDER ARTICLE TWENTY-NINE-C OF THIS CHAPTER OR A SURROGATE UNDER ARTICLE TWENTY-NINE-CC OF THIS CHAPTER; (C) "INCREASE" WHEN USED IN RELATION TO AN ORDER FOR A PSYCHOTROPIC MEDICATION, MEANS AN INCREASE OF THE DOSAGE OR DURATION OF THE MEDICA- TION ABOVE THE DOSAGE OR DURATION COVERED BY THE CURRENTLY ACTIVE CONSENT; (D) "HEALTH CARE PROFESSIONAL" MEANS A HEALTH CARE PROFESSIONAL, LICENSED, CERTIFIED OR AUTHORIZED TO PRACTICE UNDER TITLE EIGHT OF THE EDUCATION LAW, ACTING WITHIN HIS OR HER LAWFUL SCOPE OF PRACTICE, WHO HAS AUTHORITY TO ORDER A PSYCHOTROPIC MEDICATION; AND (E) "PATIENT" MEANS AN INDIVIDUAL WHO IS A RESIDENT OF A RESIDENTIAL HEALTH CARE FACILITY AS DEFINED IN ARTICLE TWENTY-EIGHT OF THIS CHAPTER, OR AN ADULT CARE FACILITY CERTIFIED UNDER SECTION FOUR HUNDRED SIXTY- ONE-B OF THE SOCIAL SERVICES LAW. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
A5332A (ACTIVE) - Details
A5332A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5332--A Cal. No. 381 2017-2018 Regular Sessions I N A S S E M B L Y February 8, 2017 ___________ Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health -- passed by Assembly and delivered to the Senate, recalled from the Senate, vote reconsidered, bill amended, ordered reprinted, retaining its place on the order of third reading AN ACT to amend the public health law, in relation to the use of psycho- tropic medications in nursing homes and adult care facilities THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 280-d to read as follows: § 280-D. USE OF PSYCHOTROPIC MEDICATIONS IN NURSING HOMES AND ADULT CARE FACILITIES. 1. AS USED IN THIS SECTION: (A) "PSYCHOTROPIC MEDICATION" MEANS A DRUG THAT AFFECTS BRAIN ACTIV- ITIES ASSOCIATED WITH MENTAL PROCESSES AND BEHAVIOR, INCLUDING, BUT NOT LIMITED TO, ANTIPSYCHOTICS, ANTIDEPRESSANTS, ANTIANXIETY DRUGS OR ANXIO- LYTICS, AND HYPNOTICS; (B) "LAWFUL REPRESENTATIVE" MEANS, WHERE A PATIENT LACKS CAPACITY TO CONSENT TO HEALTH CARE, A PERSON AUTHORIZED TO CONSENT ON BEHALF OF THE PATIENT, INCLUDING, BUT NOT LIMITED TO, A HEALTH CARE AGENT AUTHORIZED BY A HEALTH CARE PROXY UNDER ARTICLE TWENTY-NINE-C OF THIS CHAPTER OR A SURROGATE UNDER ARTICLE TWENTY-NINE-CC OF THIS CHAPTER; (C) "INCREASE" WHEN USED IN RELATION TO AN ORDER FOR A PSYCHOTROPIC MEDICATION, MEANS AN INCREASE OF THE DOSAGE OR DURATION OF THE MEDICA- TION ABOVE THE DOSAGE OR DURATION COVERED BY THE CURRENTLY ACTIVE CONSENT; (D) "HEALTH CARE PROFESSIONAL" MEANS A HEALTH CARE PROFESSIONAL, LICENSED, CERTIFIED OR AUTHORIZED TO PRACTICE UNDER TITLE EIGHT OF THE EDUCATION LAW, ACTING WITHIN HIS OR HER LAWFUL SCOPE OF PRACTICE, WHO HAS AUTHORITY TO ORDER A PSYCHOTROPIC MEDICATION; AND (E) "PATIENT" MEANS AN INDIVIDUAL WHO IS A RESIDENT OF A RESIDENTIAL HEALTH CARE FACILITY AS DEFINED IN ARTICLE TWENTY-EIGHT OF THIS CHAPTER, EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets